Ezetimibe Impurity 81 | CAS 15110-93-7 - Request Quote
Ezetimibe Impurity 81
| SZ CAT No: | SZ-E026158 |
| CAS No | 15110-93-7 |
| Mol.F. | C13H10FN |
| Mol.Wt. | 199.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 81 is chemically N-(2-fluorophenyl)-1-phenylmethanimine. Ezetimibe Impurity 81 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 81 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 15110-93-7
Purchase 15110-93-7
Order 15110-93-7
Enquire 15110-93-7
price of 15110-93-7
15110-93-7 Supplier
15110-93-7 Manufacturer
15110-93-7 Exporter
buy high quality Ezetimibe Impurity 81
Purchase Ezetimibe Impurity 81
Ezetimibe Impurity 81 suppliers
Ezetimibe Impurity 81 manufacturers
Ezetimibe Impurity 81 price
Order Ezetimibe Impurity 81
Enquire Ezetimibe Impurity 81
Ezetimibe Impurity 81 cost
Ezetimibe Impurity 81 Supplier
Ezetimibe Impurity 81 Distributor
Ezetimibe Impurity 81 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 81 for ANDA Filing
Ezetimibe Impurity 81 for Forced Degradation Studies
Ezetimibe Impurity 81 Identification Standards
Ezetimibe Impurity 81 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.